The CXCL13/CXCR5 immune axis in health and disease—Implications for intrathecal B cell activities in neuroinflammation

C Harrer, F Otto, RF Radlberger, T Moser, G Pilz… - Cells, 2022 - mdpi.com
The chemokine CXC-ligand 13 (CXCL13) is a major B cell chemoattractant to B cell follicles
in secondary lymphoid organs (SLO) that proposedly recruits B cells to the cerebrospinal …

New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine

H Xu, S Lin, Z Zhou, D Li, X Zhang, M Yu… - Cellular & Molecular …, 2023 - nature.com
Over the past thirty years, the importance of chemokines and their seven-transmembrane G
protein-coupled receptors (GPCRs) has been increasingly recognized. Chemokine …

Peripheral helper-T-cell-derived CXCL13 is a crucial pathogenic factor in idiopathic multicentric Castleman disease

T Harada, Y Kikushige, T Miyamoto, K Uno… - Nature …, 2023 - nature.com
Castleman disease (CD) is a rare lymphoproliferative disorder. Among subtypes of CD,
idiopathic multicentric CD-not otherwise specified (iMCD-NOS) has a poor prognosis and its …

Biomarkers in autoimmune diseases of the central nervous system

F Zhang, X Gao, J Liu, C Zhang - Frontiers in immunology, 2023 - frontiersin.org
The autoimmune diseases of the central nervous system (CNS) represent individual
heterogeneity with different disease entities. Although clinical and imaging features make it …

Fluid biomarkers in multiple sclerosis: from current to future applications

M Di Filippo, L Gaetani, D Centonze… - The Lancet Regional …, 2024 - thelancet.com
Multiple sclerosis (MS) is an immune-mediated inflammatory and degenerative disorder of
the central nervous system (CNS) with heterogeneous clinical manifestations. In the last …

[HTML][HTML] C4BP (β-)-mediated immunomodulation attenuates inflammation in DSS-induced murine colitis and in myeloid cells from IBD patients

I Serrano, A Luque, A Ruiz-Cerulla, S Navas… - Pharmacological …, 2023 - Elsevier
The most recent and promising therapeutic strategies for inflammatory bowel disease (IBD)
have engaged biologics targeting single effector components involved in major steps of the …

CCL21/CCR7 axis as a therapeutic target for autoimmune diseases

L Han, L Zhang - International Immunopharmacology, 2023 - Elsevier
Abstract Chemokine receptor 7 (CCR7) is a G protein-coupled receptor containing 7
transmembrane domains that is expressed on various cells, such as naive T/B cells, central …

T follicular helper cells in tertiary lymphoid structure contribute to renal fibrosis by IL-21

R Luo, D Chang, N Zhang, Y Cheng, S Ge… - International Journal of …, 2023 - mdpi.com
Tertiary lymphoid structure (TLS) represents lymphocyte clusters in non-lymphoid organs.
The formation and maintenance of TLS are dependent on follicular helper T (TFH) cells …

Distinct molecular subtypes of systemic sclerosis and gene signature with diagnostic capability

Q Wang, CL Li, L Wu, JY Hu, Q Yu, SX Zhang… - Frontiers in …, 2023 - frontiersin.org
Background As Systemic Sclerosis (SSc) is a connective tissue ailment that impacts various
bodily systems. The study aims to clarify the molecular subtypes of SSc, with the ultimate …

Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus

J Lindblom, L Beretta, MO Borghi… - Frontiers in …, 2023 - frontiersin.org
Introduction Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease that
presents a challenge for clinicians. To identify potential biomarkers for diagnosis and …